Skip to main content
Español

US FDA Approves High-Concentration, Citrate-Free Formulation of Cyltezo (adalimumab-adbm) injection

New Drug Approvals (FDA)

...- May 22, 2023 U.S. FDA Approves Cyltezo (adalimumab-adbm) as First Interchangeable Biosimilar to Humira - October 15, 2021 FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira - August 29, 2017 Cyltezo (adalimumab-adbm) FDA Approval History More news resources FDA Medwatch Drug Alerts Daily...

FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to Humira

New Drug Approvals (FDA)

...result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. Source: Alvotech Posted: February 2024 Simlandi (adalimumab-ryvk) FDA Approval History More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health...

Select Strengths of Sandoz Biosimilar Hyrimoz Granted Interchangeability by FDA

New Drug Approvals (FDA)

...(adalimumab-adaz) FDA Approval History More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to our newsletter Whatever your topic of interest, subscribe to our...

FDA Approves Tyenne (tocilizumab-aazg), a Biosimilar to Actemra

New Drug Approvals (FDA)

...this release. Source: Fresenius Kabi Posted: March 2024 Tyenne (tocilizumab-aazg) FDA Approval History More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe...

News: Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa

News & Articles (Drugs.com)

Barbae Care MONDAY, Dec. 11, 2023 -- An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New...

News: Monthly News Roundup - February 2024

News & Articles (Drugs.com)

Monthly News Roundup - February 2024 Medically reviewed by Leigh Ann Anderson, PharmD . Last updated on March 1, 2024. Tecvayli Approved for Biweekly Dosing in Multiple Myeloma In February, the U.S. Food and Drug Administration (FDA) approved biweekly (every 2 weeks) dosing for Tecvayli...

FDA Alert: FDA Approves Boxed Warning About Increased Risk of Blood Clots and Death with Higher Dose of Tofacitinib (Xeljanz, Xeljanz XR)

Drug Alerts (FDA)

...immediately if they experience unusual symptoms, including those of thrombosis. Encourage patients to read the Medication Guide they receive with each tofacitinib prescription, which explains the safety risks and provides other important information. Source: FDA More news resources FDA Medwatch Drug Alerts...

Coherus Announces FDA Approval of Udenyca Onbody™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

New Drug Approvals (FDA)

History More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to our newsletter Whatever your topic of interest, subscribe to our newsletters to get the best...